CIMADAMORE, Alessia
 Distribuzione geografica
Continente #
EU - Europa 33
NA - Nord America 16
AS - Asia 5
AF - Africa 1
Totale 55
Nazione #
US - Stati Uniti d'America 16
FR - Francia 14
IT - Italia 9
NL - Olanda 4
UA - Ucraina 3
IN - India 2
PT - Portogallo 2
DZ - Algeria 1
HK - Hong Kong 1
IQ - Iraq 1
KR - Corea 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 55
Città #
La Roche-sur-Yon 5
Rome 5
Amsterdam 4
Boardman 4
Columbus 2
Council Bluffs 2
Kolkata 2
Al Hillah 1
Amadora 1
Ashburn 1
Charlestown 1
Daegu 1
Košice 1
Milan 1
Naples 1
Paris 1
Plainsboro 1
Porto 1
Scandicci 1
Wanchai 1
Totale 37
Nome #
Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype, file 3c968b80-10d1-44b4-9ea5-9e065252c4d3 27
News in the classification of WHO 2022 bladder tumors, file 6516cdfc-6ad3-493d-b1f7-abcaf07f0243 11
Morphologic spectrum of the epithelial tumors of the male and female urethra, file 280fd4c2-6f27-4a87-93b2-598f714f9af4 5
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B), file ed0998e9-cd7f-48b1-88e2-3c6f85ac6750 5
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation, file 03f7d9f4-9435-44c9-be98-69bea37e2661 3
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis, file 88d91ade-c42f-43e3-83bf-73f9a8c1ca8e 2
Emerging Molecular Technologies in Genitourinary Tumors, file 0b841b68-f71b-4310-84f7-1ff8de620b86 1
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A), file 2290db00-a910-49f3-a6d1-db95b6ed5d54 1
Totale 55
Categoria #
all - tutte 311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20238 0 0 0 0 0 0 0 0 1 1 3 3
2023/202447 4 1 2 1 2 9 1 9 1 13 4 0
Totale 55